Terms: = Endocrine gland cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Treatment
160 results:
1. Comparison of clinical efficacy and safety between robotic-assisted and laparoscopic adrenalectomy for pheochromocytoma: a systematic review and meta-analysis.
Wang L; Zeng W; Wu Y; Gong Z
J Robot Surg; 2024 Mar; 18(1):115. PubMed ID: 38466492
[TBL] [Abstract] [Full Text] [Related]
2. Potential Added Value of
Chen S; Wang G; Wu L; Chen D; Fang K; Liu W; Xu B; Zhai YQ; Li M
BMC Gastroenterol; 2024 Jan; 24(1):37. PubMed ID: 38233765
[TBL] [Abstract] [Full Text] [Related]
3.
Li X; Lu N; Lin L; Chen Y; Yang S; Wang H; Liu X; Wu C; Xue X; Su X; Bai X; Liang T
J Nucl Med; 2024 Feb; 65(2):206-212. PubMed ID: 38176719
[TBL] [Abstract] [Full Text] [Related]
4. Prediction of
Mileva M; Marin G; Levillain H; Artigas C; Van Bogaert C; Marin C; Danieli R; Deleporte A; Picchia S; Stathopoulos K; Jungels C; Vanderlinden B; Paesmans M; Ameye L; Critchi G; Taraji-Schiltz L; Velghe C; Wimana Z; Bali M; Hendlisz A; Flamen P; Karfis I
J Nucl Med; 2024 Feb; 65(2):236-244. PubMed ID: 38164576
[TBL] [Abstract] [Full Text] [Related]
5. Methylation-Mediated Silencing of ATF3 Promotes Thyroid cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways.
Xiao X; Chen M; Sang Y; Xue J; Jiang K; Chen Y; Zhang L; Yu S; Lv W; Li Y; Liu R; Xiao H
Thyroid; 2023 Dec; 33(12):1441-1454. PubMed ID: 37742107
[No Abstract] [Full Text] [Related]
6. Reduced uptake pattern on
de Jong MC; Pinto D; Parameswaran R
J Surg Oncol; 2023 Oct; 128(5):764-768. PubMed ID: 37403579
[TBL] [Abstract] [Full Text] [Related]
7. Comparison of the Efficiency of Radiofrequency and Microwave Ablation Methods in the treatment of Benign Thyroid Nodules.
Cerit MN; Yücel C; Cerit ET; Yalçın MM; Şendur HN; Oktar SÖ
Acad Radiol; 2023 Oct; 30(10):2172-2180. PubMed ID: 37357048
[TBL] [Abstract] [Full Text] [Related]
8. Tumor Characterization by [
Rasinski P; Af Burén S; Holstensson M; Nilsson T; Loizou L; Tran TA; Sparrelid E; Löhr JM; Axelsson R
J Nucl Med; 2023 Aug; 64(8):1232-1237. PubMed ID: 37348917
[TBL] [Abstract] [Full Text] [Related]
9. [
Zhu Z; Cheng K; Yun Z; Zhang X; Hu X; Liu J; Wang F; Fu Z; Yue J
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3425-3438. PubMed ID: 37328622
[TBL] [Abstract] [Full Text] [Related]
10. Initial Evaluation of [
Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
[TBL] [Abstract] [Full Text] [Related]
11. Visualization research on ENT1/NIS dual-function gene therapy to reverse drug resistance mediated by MUC1 in GEM-resistant pancreatic cancer.
Xi Y; Chen H; Xi Y; Hai W; Qu Q; Zhang M; Li B
Nucl Med Biol; 2023; 120-121():108350. PubMed ID: 37229950
[TBL] [Abstract] [Full Text] [Related]
12. The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients.
Mauguen A; Grewal RK; Augensen F; Abusamra M; Mahajan S; Jayaprakasam VS; Osborne J; Haque S; Wong BZY; Ghossein RA; Fagin J; Schӧder H; Tuttle RM; Ho A; Humm JL; Larson SM
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):2971-2983. PubMed ID: 37171634
[TBL] [Abstract] [Full Text] [Related]
13. A comparative study of [
Xi Y; Sun L; Che X; Huang X; Liu H; Wang Q; Meng H; Miao Y; Qu Q; Hai W; Li B; Feng W
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2885-2898. PubMed ID: 37093313
[TBL] [Abstract] [Full Text] [Related]
14. Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer.
de Jong LAW; Lambert M; van Erp NP; de Vries L; Chatelut E; Ottevanger PB
Cancer Chemother Pharmacol; 2023 Mar; 91(3):247-256. PubMed ID: 36892677
[TBL] [Abstract] [Full Text] [Related]
15. Efficacy and Safety of
Maric I; Weber M; Prochnow A; Schmitz J; Unger N; Schaarschmidt BM; Poeppel TD; Rischpler C; Bockisch A; Herrmann K; Jentzen W; Fendler WP
J Nucl Med; 2023 Jun; 64(6):885-891. PubMed ID: 36732054
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic value of preoperative [
Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Huo L; Li X
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1780-1791. PubMed ID: 36695823
[TBL] [Abstract] [Full Text] [Related]
17. Discovery of Highly Potent Nicotinamide Phosphoribosyltransferase Degraders for Efficient treatment of Ovarian cancer.
Bi K; Cheng J; He S; Fang Y; Huang M; Sheng C; Dong G
J Med Chem; 2023 Jan; 66(1):1048-1062. PubMed ID: 36563407
[TBL] [Abstract] [Full Text] [Related]
18. 68 Ga-Prostate-Specific Membrane Antigen PET/CT in Ovarian Tumors : Potential to Differentiate Benign and Malignant Tumors Before Surgery: A Preliminary Report.
Kunikowska J; Bizoń M; Pełka K; Derlatka P; Olszewski M; Królicki L
Clin Nucl Med; 2023 Feb; 48(2):e60-e66. PubMed ID: 36512649
[TBL] [Abstract] [Full Text] [Related]
19. Risk of thrombosis in women with cancer undergoing controlled ovarian hyperstimulation for fertility preservation.
Melo VD; Liseth OY; Schmidt WM; Pruthi RK; Marshall AL; Shenoy CC
J Assist Reprod Genet; 2022 Dec; 39(12):2847-2856. PubMed ID: 36427171
[TBL] [Abstract] [Full Text] [Related]
20. Nose-to-brain delivery of octreotide acetate in situ gel for pituitary adenoma: Pharmacological and in vitro cytotoxicity studies.
Gadhave D; Khot S; Tupe S; Shinde M; Tagalpallewar A; Gorain B; Kokare C
Int J Pharm; 2022 Dec; 629():122372. PubMed ID: 36351503
[TBL] [Abstract] [Full Text] [Related]
[Next]